NCT05907681Recruiting
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Source: ClinicalTrials.gov · Last updated 29 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 8 Jun 2023
- Start date
- 11 May 2023
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Samsung Medical Center
- Diseases
- Metastatic breast cancer
- NCT number
- NCT05907681
What you commit to
- Study type: Observational
- Planned participants: 400
- From 11 May 2023 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- unable to adhere to the study protocol
Who the study is looking for
- histologically confirmed breast cancer
- presence of distant metastasis
- radiation therapy using IMRT, SBRT, or proton therapy is done or planned
- Able and willing to comply with the study protocol
Age in the registry: 19 years to 100 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samsung Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.